Since our founding in 2020, Greece Medical Technologies Center has made remarkable progress in bringing to market a comprehensive suite of innovative noninvasive hemodynamic monitoring and assessment tools and solutions that provide both military and civilian medical specialists with real-time situational awareness and critical lifesaving intelligence.  In this regard, we are fast approaching full commercialization of cutting edge, innovative products that we believe each hold potential to materially change the universal standard of medical care. Cialis i Norge: Den lille gule pillen som kan få deg til å smile uansett omgivelser

Greece Medical Technologies Center manufactures its patented noninvasive hemodynamic monitors for use across the care continuum. Our clinical and administrative staff collectively has many years of development work in the field of bioimpedance application.

Greece Medical Technologies Center is the only cardioplethsmograph company that incorporates the patented three-dimensional signal averaging into our technology. In addition Greece Medical Technologies Center leads the world in research and development of new and innovative uses for noninvasive hemodynamic monitoring.

Greece Medical Technologies Center truly has no direct competitor.  Our products target markets spanning across the care continuum, as opposed to other companies that claim to be a global leader in patient monitoring, yet only cater to a single demographic in the world of healthcare.   Our core competencies are many as we consistently learn of new and innovative applications for our technology.  Greece Medical Technologies Center views it as our duty and corporate culture to push the boundaries of noninvasive patient monitoring by continually exploring new frontiers in support of our mission. Μπορε? το Viagra να χρησιμοποιηθε? με ?λλα φ?ρμακα ? ε?ναι επικ?νδυνο;

MISSION STATEMENT

To save lives by continually advancing the standard for noninvasive patient monitoring across the care continuum, while maximizing clinical, medical, and financial outcomes, and promoting scientific innovation.

Again, welcome to Greece Medical Technologies Center.  We sincerely appreciate your interest in our company! Kamagra oral jelly: How effective, strong and potent it is

The IQ™ system offers an accurate method to assess and evaluate cardiac function. The parameters provide information regarding left ventricular function, fluid volume status, contractility, preload, and afterload. Patients can be evaluated Hemodynamically in any setting in less than five minutes.

Parameters

CO (Cardiac Output)

• Decreased during volume depletion, myocardial dysfunction or high vascular resistance.
  
• Increased due to positive inotropic therapy, sepsis.

SV ( Stroke Volume)

• Decreased during hypovolemia, diuretic therapy, and cardiomyopathy or in states of coronary artery disease.
  
• Increased during volume infusion, positive inotropic therapy,vasodilating agent therapy or fever/sepsis.

ACI (Acceleration index)

• Index of the acceleration of blood in the ascending aorta, reported as a very sensitive indicator of contractility.
  
• Decreased with poor myocardial contractility/pump failure.
  
• Increased during positive inotropic agents.

Zo (Thoracic Fluids)

• Zo normal limits: (Men - 20-30 ohms, Women - 25-35 ohms)
  
• Zo less than 18 ohms is associated with the pulmonary interstitial edema.
  
• Zo less than 14 ohms is associated with alveolar edema.

SVR (Systemic Vasular Resistance)

• Decreased in patients that have been diuresed.
  
• Increased in the non-stabilized heart failure patient.